Deal Snapshot
TAKARA BIO TO BUY US GENOMICS SPECIALIST WAFERGEN BIO-SYSTEMS FOR UP TO USD 50M
Monday 16 May 2016

Japanese biotechnology company Takara Bio Inc.'s (TSX: 4974) Takara Bio USA Holdings, Inc. unit has agreed to acquire US-based genomics technology company WaferGen Bio-systems, Inc. (NASDAQ: WGBS), the companies said.
Under the terms of the merger agreement, TBUSH will acquire WaferGen for an aggregate cash purchase price that will be based on a multiple of WaferGen's 2016 calendar revenue and capped at USD 50m, subject to the potential adjustments described below.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 16/05/2016
Target: WaferGen Bio-systems, Inc
Country: USA
Deal Size: 50m (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Cash
Status: Agreed
Vendor:
Buyer: Takara Bio,  USA Holdings
Buyer Advisor: GCA Savvian , Morrison and Foerster LLP
Comment:


Options